|
|
 |
|
Viewing report
|
|
|
|
AstraZeneca PLC - SWOT Analysis
MarketLine, July 2011, Pages: 29
AstraZeneca PLC - SWOT Analysis company profile is the essential source for top-level company data and information. AstraZeneca PLC - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
AstraZeneca is the second largest biopharmaceutical company in the UK. The company was formed in 1999 by the merger of Swedish-based Astra and UK-based Zeneca Group. AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra. The company is headquartered in London and employed about 61,000 people as of December 31, 2010. The company recorded revenues of $33,269 million during the financial year (FY) ended December 2010, an increase of 1.4% over FY2009. The operating profit of the company was $11,494 million during FY2010, a decrease of 0.4% over FY2009. The net profit was $8,081 million in FY2010, an increase of 7.1% over FY2009.
Scope of the Report
- Provides all the crucial information on AstraZeneca PLC required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of AstraZeneca PLC
-Data is supplemented with details on AstraZeneca PLC history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from AstraZeneca PLC
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
